Age-Related Macular Degeneration
VIDEO: Modifiable risk factors of dry AMD
In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses what physicians can tell patients with dry AMD to help them prevent their condition from worsening, such as quitting smoking and taking AREDS supplements.
EyePoint Pharmaceuticals’ EYP-1901: Promising Novel Drug Delivery System
In this episode, I chat with Nancy Lurker, CEO and board director, about EyePoint Pharmaceuticals and their latest treatments and trials.
‘You are what you eat’: How healthy eating and living can benefit eyes, lower AMD risk
The link between nutrition and ocular health became apparent in the early 1990s as epidemiologists and ophthalmologists uncovered dietary patterns in patients with AMD.
Samsara Vision’s SING IMT: Game Changer for the Advanced AMD Patient
In this episode, I discuss Samsara Vision’s SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD.
Q&A: State of diagnosis, screening in AMD
Earlier diagnosis of certain types of age-related macular degeneration is integral to preserve vision for patients.
VIDEO: Retina patients respond better to therapy when sleep disorders are treated
ATLANTA — A strong association exists between sleep disorders and conditions such as diabetic retinopathy and age-related macular degeneration, Paul Chous, MA, OD, FAAO, said at SECO 100.
Study dispels potential immunogenicity concerns regarding ranibizumab biosimilar
A post hoc analysis of phase 3 trial data showed no association of immunogenicity with efficacy or safety for both ranibizumab and the biosimilar SB11 in patients with neovascular age-related macular degeneration.
Inconsistent practitioner advice leads to poor compliance in patients with AMD
Lifestyle advice given to patients with age-related macular degeneration varies and often is not followed, highlighting the need for a better understanding of patient preferences, according to a literature review in Nutrients.
Nascent geographic atrophy observed on early OCT may reliably indicate GA progression
KOLOA, Hawaii — Nascent geographic atrophy may be a reliable indicator for progression to geographic atrophy, which could help with age-related macular degeneration interventions when detected early through OCT.
FDA approves ML6710i photodynamic laser for use with Visudyne
The FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s Visudyne photodynamic therapy for the treatment of classic subfoveal choroidal neovascularization due to age-related macular degeneration.